Valeant Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for VALEANT PHARMS, and when can generic versions of VALEANT PHARMS drugs launch?
VALEANT PHARMS has twenty-two approved drugs.
There are six US patents protecting VALEANT PHARMS drugs.
There are forty-four patent family members on VALEANT PHARMS drugs in twelve countries and eighteen supplementary protection certificates in twelve countries.
Summary for Valeant Pharms
International Patents: | 44 |
US Patents: | 6 |
Tradenames: | 17 |
Ingredients: | 15 |
NDAs: | 22 |
Drugs and US Patents for Valeant Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Valeant Pharms Intl | GIAZO | balsalazide disodium | TABLET;ORAL | 022205-001 | Feb 3, 2012 | DISCN | Yes | No | 7,452,872 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms North | FENOFIBRATE | fenofibrate | TABLET;ORAL | 090715-002 | Apr 5, 2012 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Valeant Pharms North | DERMATOP | prednicarbate | OINTMENT;TOPICAL | 019568-001 | Sep 23, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Valeant Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-002 | Sep 8, 2005 | 6,254,887 | ⤷ Try a Trial |
Valeant Pharms | ULTRAM ER | tramadol hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 021692-002 | Sep 8, 2005 | 7,074,430 | ⤷ Try a Trial |
Valeant Pharms North | RENOVA | tretinoin | CREAM;TOPICAL | 019963-001 | Dec 29, 1995 | 4,423,041 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for VALEANT PHARMS drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Extended-release Tablets | 100 mg | ➤ Subscribe | 2007-01-08 |
➤ Subscribe | Extended-release Tablets | 300 mg | ➤ Subscribe | 2007-09-25 |
➤ Subscribe | Cream | 0.5% | ➤ Subscribe | 2011-07-29 |
➤ Subscribe | Extended-release Tablets | 200 mg | ➤ Subscribe | 2007-03-28 |
➤ Subscribe | Tablets | 1.1 g | ➤ Subscribe | 2013-11-05 |
International Patents for Valeant Pharms Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Canada | 2816276 | ⤷ Try a Trial |
World Intellectual Property Organization (WIPO) | 2011137103 | ⤷ Try a Trial |
South Korea | 20140098863 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Valeant Pharms Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0566709 | C300152 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405 |
1304992 | 1390049-3 | Sweden | ⤷ Try a Trial | PRODUCT NAME: KLINDAMYCIN (SOM KLINDAMYCINFOSFAT) OCH TRETINOIN; NAT. REG. NO/DATE: MTNR 46193 20130503; FIRST REG.: IR PA1332/043/001 20130322 |
0617614 | 2001/009 | Ireland | ⤷ Try a Trial | PRODUCT NAME: PANRETIN-ALITRETINOIN |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.